Functional partial agonism at cloned human muscarinic acetylcholine receptors

European Journal of Pharmacology

Volumn 313, Issue 1-2, 1996, Pages 145-150

  Bräuner Osborne, Hans ^a   Ebert, Bjarke ^a   Brann, Mark R ^b,c   Falch, Erik ^a   Krogsgaard Larsen, Povl ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF VERMONT   (United States)

^c ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

Cloned human receptor; Functional partial agonism; Functional receptor selectivity; Muscarinic acetylcholine receptor; Receptor selection and amplification technology

Indexed keywords

ATROPINE; CARBACHOL; MUSCARINIC RECEPTOR; PIRENZEPINE; PROTEIN G; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0030579063     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00501-8     Document Type: Article

References (24)

1. Bonner, T.I., N.J. Buckley, A.C. Young and M.R. Brann, 1987, Identification of a family of muscarinic acetylcholine receptor genes, Science 237, 527.
2. Bonner, T.I., A.C. Young, M.R. Brann and N.J. Buckley, 1988, Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes, Neuron 1, 403.
3. Bräuner-Osborne, H. and M.R. Brann, 1996, Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells, Eur. J. Pharmacol. 295, 93.
4. Bräuner-Osborne, H., B. Ebert, M.R. Brann, E. Falch and P. Krogsgaard-Larsen, 1995, Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors, J. Med. Chem. 38, 2188.
5. Burstein, E.S., T.A. Spalding, H. Bräuner-Osborne and M.R. Brann, 1995, Constitutive activation of muscarinic receptors by the G protein Gq, FEBS Lett. 363, 261.
6. Christensen, I.T., A. Reinhardt, B. Nielsen, B. Ebert, E.Ø. Nielsen and P. Krogsgaard-Larsen, 1989, Excitatory amino acid agonists and partial agonists, Drug Des. Del. 5, 57.
7. Conklin, B.R., Z. Farfel, K.D. Lustig, D. Julius and H.R. Bourne, 1993, Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha, Nature (London) 363, 274.
8. Ebert, B., S. Lenz, L. Brehm, P. Bregnedal, J.J. Hansen, K. Frederiksen, K.P. Bøgesø and P. Krogsgaard-Larsen, 1994a, Resolution, absolute stereochemistry, and pharmacology of the S-(+)-and R-(-)-isomers of the apparant partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA], J. Med. Chem. 37, 878.
9. Ebert, B., U. Madsen, T.M. Lund, S.M. Lenz and P. Krogsgaard-Larsen, 1994b, Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazoyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA, Neurochem. Int. 24, 507.
10. Ebert, B., K.K. Søby, U. Madsen and P. Krogsgaard-Larsen, 1995, Glutamic acid receptors in schizophrenia and Alzheimer's disease: functional partial agonism and receptor modulation as potential therapeutic approaches, in: Schizophrenia, Alfred Benzon Symposium 38, eds. R. Fog, J. Gerlach and R. Hemmingsen (Munksgaard, Copenhagen) p. 379.
11. Ebert, B., U. Madsen, K.K. Søby and P. Krogsgaard-Larsen, 1996, Functional partial agonism as demonstrated for ionotropic glutamate receptors, Neurochem. Int. (in press).
12. Feuerstein, T.J., W. Sauermann, C. Allgaier, E. Agneter and E.A. Singer, 1994, New insights into receptor theory, as provided by an artificial partial agonist made-to-measure, Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 1.
13. Gutkind, J.S., E.A. Novotny, M.R. Brann and K.C. Robbins, 1991, Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes, Proc. Natl. Acad. Sci. USA 88, 4703.
14. Hu, J., S.Z. Wang and E.E. El-fakahany, 1991, Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells, J. Pharmacol. Exp. Ther. 257, 938.
15. Kenakin, T.P. and P.H. Morgan, 1989, Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists, Mol. Pharmacol. 35, 214.
16. Lim, K. and C.-B. Chae, 1989, A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase, BioTechniques 7, 576.
17. Messier, T.L., C.M. Dorman, H. Bräuner-Osborne, D. Eubanks and M.R. Brann, 1995, High throughput assays of cloned adrenergic, muscarinic, neurokinin, and neurotrophin receptors in living mammalian cells, Pharmacol. Toxicol. 76, 308.
18. Pontzer, N.J. and F.T. Crews, 1990, Desensitization of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium, J. Pharmacol. Exp. Ther. 253, 921.
19. Thompson, A.K. and S.K. Fisher, 1990, Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations, J. Pharmacol. Exp. Ther. 252, 744.
20. Waud, D.R., 1975, Analysis of dose-response curves, in: Methods in Pharmacology, Vol. 3, eds. E.E. Daniel and D.M. Paton (Plenum, New York) p. 471.
21. Whitehouse, P.J., 1993, Cholinergic therapy in dementia, Acta Neurol. Scand. Suppl. 149, 42.
22. Wigler, M., S. Silverstein, L.-S. Lee, A. Pellicer, Y.-C. Cheng and R. Axel, 1977, Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells, Cell 11, 223.
23. Williams, M., D.C. Deecher and J.P. Sullivan, 1995, Drug receptors, in: Burger's Medicinal Chemistry and Drug Discovery, Vol. 1: Principles and Practice, ed. M.E. Wolff (John Wiley & Sons, New York) p. 349.
24. Winding, B. and N. Bindslev, 1993, Desensitization and reactivation of ACh-regulated exocrine secretion in hen tracheal epithelium, Am. J. Physiol. 264, C342.